SurgoCap Partners LP: TAIWAN SEMICONDUCTOR MANUFAC (TSM): Quarterly 13F Position History
As of Q2 2026, SurgoCap Partners LP reported 908,064 shares of TAIWAN SEMICONDUCTOR MANUFAC (TSM), worth $433.7M and representing 14.0% of its 13F equity book. Quarter-over-quarter share count change: 200,009 (-18.1%) . The position first appeared in Q3 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.
- 908,064Shares Held (Latest Filing)
- $433.7MReported Market Value (Latest Filing)
- 14.0%Portfolio Weight (% of 13F Equity Book)
- 200,009Quarter-over-Quarter Share Change
- +$59.2MQuarter-over-Quarter Value Change
- 1,290,570Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 908,064 | 200,009 | -18.1% | $433.7M | 14.0% | $477.6 |
| Q1 2026 | 1,108,073 | 1,510 | -0.1% | $374.5M | 12.5% | $337.9 |
| Q4 2025 | 1,109,583 | 180,987 | -14.0% | $337.2M | 9.3% | $303.9 |
| Q3 2025 | 1,290,570 | – | – | $360.4M | 10.2% | $279.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did SurgoCap Partners LP first disclose a TSM position in 13F-HR filings?
SurgoCap Partners LP first reported TAIWAN SEMICONDUCTOR MANUFAC (TSM) on its 13F-HR filing for the period ending 2025-09-30 (Q3 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.
What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in TSM?
Between Q1 2026 and Q2 2026, SurgoCap Partners LP reduced its TSM position by 200,009 shares (-18.1%), leaving 908,064 shares at a market value of $433.7M.
Does the implied price-per-share represent SurgoCap Partners LP's cost basis in TSM?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.